Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Global Hemp Group (GHG) has executed a binding letter of intent with Apollon Formularies
  • According to the LOI, Global Hemp Group will acquire an exclusive, perpetual license for North America for certain Apollon intellectual property
  • This will include four key patents and any associated preclinical and clinical data relating to the patents
  • Shares of Global Hemp Group are up 50 per cent C$0.015 as of 12:31 p.m. EST on Tuesday

Global Hemp Group Inc. (GHG) has entered into a binding letter of intent (LOI) with Apollon Formularies.

Under the terms of the LOI, Global Hemp Group will acquire an exclusive license in the US, Canada and Mexico for certain Apollon intellectual property and proprietary technologies and any associated preclinical data.

The intellectual property and proprietary technologies include:

  • Compositions and Methods for Treatment of Cancers;
  • Compositions and Methods for Treatment of Inflammation;
  • Methods for Treatment of Human Cancers Using Cannabis Compositions;
  • Methods for Treatment of Human Cancers Using Mushroom Compositions;
  • BIOENSIS Preclinical Data reflecting independent 3D cell culture testing of cannabis and mushroom formulations included in the patent applications.

These patents include claims to the treatments of cancers and inflammatory conditions using natural biologics, including compounds in medical cannabis, functional mushrooms, and psychedelic mushrooms.

Global Hemp Group will also have the rights to sublicense the intellectual property to licensed producers in the US, Canada and Mexico.

Global Hemp Group will also pay a total of US$250,000 in two separate tranches and issue Apollon 10 million common shares at a price of C$0.015 per share. Global Hemp Group will also pay to Apollon ongoing licensing fees related to the IP.

Apollon Formularies is a UK-based pharmaceutical company developing cancer treatments from natural biologics such as medical cannabis, functional mushrooms and psychedelic mushrooms. Apollon uses an artificial intelligence-based drug discovery platform.

Shares of Global Hemp Group are up 50 per cent C$0.015 as of 12:31 p.m. EST on Tuesday.


More From The Market Herald

" @ the Bell: Markets tumble amid rate worries

Canada’s main stock index was weighed down on Monday by commodity-linked and financial stocks. The telecom and utilities sectors posted some gains.
Dolly Varden Silver Corporation - President & CEO, Shawn Khunkhun.

" Dolly Varden Silver (TSXV:DV) reports highest-grade silver assay found so far on the Kitsault Valley Property

Dolly Varden Silver Corporation (DV) discovered the highest-grade silver assay found so far on the Kitsault Valley Property.

" Black Tusk Resources (CSE:TUSK) acquiring PegaLith Project

Black Tusk Resources (TUSK) has signed a $361,000 share purchase agreement to acquire 1396427 BC Ltd.

" Deep South Resources (TSXV:DSM) closes oversubscribed non-brokered private placement

Deep-South Resources (DSM) has closed the final tranche of an oversubscribed, non-brokered private placement for gross proceeds of $490,000.